← Back to Clinical Trials
Recruiting NCT06274957

The Effect of Airway and Chest Wall Oscillation on Respiratory Functions in COPD Patients in Acute Exacerbation

Trial Parameters

Condition COPD Exacerbation Acute
Sponsor Saglik Bilimleri Universitesi
Study Type INTERVENTIONAL
Phase N/A
Enrollment 27
Sex ALL
Min Age 40 Years
Max Age N/A
Start Date 2024-05-01
Completion 2024-06-10
Interventions
CONTROLPEP DEVICEHFCWO DEVICE

Brief Summary

Chronic obstructive pulmonary disease (COPD); It is a common, treatable and preventable disease characterized by progressive and irreversible airflow limitation and has systemic effects with respiratory system involvement. Increased respiratory workload, decreased work .

Eligibility Criteria

Inclusion Criteria: * Being classified as GOLD stage 3 or 4 based on spirometric evaluation in the medical history. * Having a hospital admission within the specified time frame, evaluated by a pulmonary specialist, and admitted to the pulmonary diseases service with a diagnosis of COPD exacerbation. * Being 40 years of age or older. * Voluntarily agreeing to participate in the study. Exclusion Criteria: * Having a hospital admission with a diagnosis of asthma attack in the last 5 years. * Monitoring suspicious focal points for pneumonia on lung radiology. * Hospitalization due to reasons other than exacerbation despite having a diagnosis of COPD. * Presence of pulmonary fibrosis or suspicious findings of fibrosis on radiology. * Systemic fungal infections. * Having cognitive impairment affecting the decision to participate in the study, such as confusion, orientation disorder, or dementia. * Patients with lung cancer or metastasis in the lungs. * Diagnosis of conditions provoking shor

Related Trials